Updated Jul 16, 2026
Sepp-Lorenzino Laura has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the provided SEC filing context (Taysha Gene Therapies, Inc., as of 2026-06-02), Sepp-Lorenzino Laura is a person associated with the company in the insider/SEC filing context. The filing context does not specify a title or detailed background. No independently verifiable biographical details are confirmed from publicly available sources within this context. Verification from the actual SEC filings (e.g., Form 4, Form 13D/13F, or 8-K disclosures) or the company's investor relations materials would be required to determine current role, background, and notable achievements.
| Role | Insider |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | TSHA | Taysha Gene Therapies, Inc. | A — Grant or award | 21.3K | $0.00 |
Based on the provided SEC filing context (Taysha Gene Therapies, Inc., as of 2026-06-02), Sepp-Lorenzino Laura is a person associated with the company in the insider/SEC filing context. The filing context does not specify a title or detailed background. No independently verifiable biographical details are confirmed from publicly available sources within this context. Verificati…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sepp-Lorenzino Laura profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.